Categories: EHRNews

MedsEngine Presents at ESC in London, U.K.

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

DAYTON, Ohio–(BUSINESS WIRE)–MedsEngine LLC is a clinical decision support company that develops software for treating chronic disease. Data was presented on cerebrovascular events and myocardial infarctions in patients treated with MedsEngine-Hypertension at the 2024 European Society of Cardiology Congress in London, U.K.


Hypertension is recognized as a leading cause of atherosclerotic cardiovascular disease and death globally. Data was retrieved from EHRs for a period of seven years for patients with hypertension managed with MedsEngine (average age 61) and patients with normal blood pressure (average age 43). Comparable cerebrovascular and MI events were observed (10/1000 and 4.2/1000 patients, respectively). This observation is noteworthy as it suggests controlling hypertension reduces strokes and MIs to the rate of a non-hypertensive 43-year-old.

Dr. Doug Romer, COO/CMO of MedsEngine, stated, “Utilizing MedsEngine-Hypertension, that incorporates hemodynamic data and a proprietary algorithm to control hypertension, can have a positive impact on the occurrence of strokes and heart disease. MedsEngine has demonstrated blood pressure control rates of 92% (<140/90) for 10 consecutive years.”

MedsEngine will have a booth at the AHA Hypertension Scientific Session in Chicago from September 5-8. Stop by to learn more about the benefits of MedsEngine.

About MedsEngine

MedsEngine develops EHR-integrated clinical decision support applications that generate real-time, personalized, evidence-based medication recommendations for Hypertension, Cholesterol Management, Type 2 Diabetes, and Heart Failure. For more information, visit http://www.medsengine.com.

Contacts

hello@medsengine.com

Staff

Recent Posts

Cosmo to Unveil First-of-its-Kind Clinical Study on the Use of GI Genius(TM) with Apple Vision Pro at Rush University Medical Center

Dublin, Ireland--(Newsfile Corp. - June 24, 2025) - Cosmo Pharmaceuticals N.V. (“Cosmo”) today announced that…

2 hours ago

TKSoftware Inc. Unveils ICONIC Pro: The All-In-One Medical Billing & Clearinghouse Solution

TKSoftware Inc. today launches ICONIC Pro, a unified, cloud–based platform that combines claims submission, electronic…

4 hours ago

Monarch Athletic Club: A Longevity Clinic Disguised as an Athletic Club

LOS ANGELES, June 23, 2025 /PRNewswire/ -- Monarch Athletic Club, the Los Angeles-based wellness disruptor…

4 hours ago

ZEISS Vision Care US Names Healthcare Industry Veteran Gary Rosenblum as President and Chief Executive Officer

Most Recently Serving as President for Oticon, a Division of Demant, Rosenblum Brings 30+ Years…

7 hours ago

TriSalus Life Sciences Announces Commencement of Exchange Offer and Consent Solicitation Relating to Series A Convertible Preferred Stock to Streamline Capital Structure

WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences® Inc. (Nasdaq: TLSI), a company working to improve outcomes for…

10 hours ago

As Dangerous US Heat Wave Intensifies, AccuWeather Urges Public to Rely on Science-Backed RealFeel® Temperature for Accurate Danger Index

AccuWeather's RealFeel® Temperature is the only authentic formula-based metric—unlike 'Feels Like,' which lacks scientific credibility.Request…

10 hours ago